Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test.

Parker AC, Preston T, Heaf D, Kitteringham NR, Choonara I.

Br J Clin Pharmacol. 1994 Dec;38(6):573-6.

2.

Enhanced drug metabolism in young children with cystic fibrosis.

Parker AC, Pritchard P, Preston T, Smyth RL, Choonara I.

Arch Dis Child. 1997 Sep;77(3):239-41.

3.

Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test.

Parker AC, Pritchard P, Preston T, Choonara I.

Br J Clin Pharmacol. 1998 Feb;45(2):176-8.

4.

Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test.

Parker AC, Pritchard P, Preston T, Dalzell AM, Choonara I.

Br J Clin Pharmacol. 1997 May;43(5):467-70.

6.

The effect of age, gender, and sexual maturation on the caffeine breath test.

Lambert GH, Schoeller DA, Kotake AN, Flores C, Hay D.

Dev Pharmacol Ther. 1986;9(6):375-88.

PMID:
3102191
8.

Caffeine metabolism in cystic fibrosis: enhanced xanthine oxidase activity.

Hamelin BA, Xu K, Vallé F, Manseau L, Richer M, LeBel M.

Clin Pharmacol Ther. 1994 Nov;56(5):521-9.

PMID:
7955816
9.

The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity.

Fontana RJ, Turgeon DK, Woolf TF, Knapp MJ, Foster NL, Watkins PB.

Hepatology. 1996 Jun;23(6):1429-35.

PMID:
8675160
11.

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.

Bertilsson L, Carrillo JA, Dahl ML, Llerena A, Alm C, Bondesson U, Lindström L, Rodriguez de la Rubia I, Ramos S, Benitez J.

Br J Clin Pharmacol. 1994 Nov;38(5):471-3.

12.
13.

Liver disease does not affect lipolysis as measured with the 13C-mixed triacylglycerol breath test in children with cystic fibrosis.

Ling SC, Amarri S, Slater C, Hollman AS, Preston T, Weaver LT.

J Pediatr Gastroenterol Nutr. 2000 Apr;30(4):368-72.

PMID:
10776945
14.

Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.

Danie WA, Syrek M, Ryłko Z, Wójcikowski J.

Pol J Pharmacol. 2001 Jul-Aug;53(4):351-7.

15.
16.

The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

Batty KT, Davis TM, Ilett KF, Dusci LJ, Langton SR.

Br J Clin Pharmacol. 1995 Mar;39(3):305-11.

17.

Improving the specificity of the [13C]mixed triacylglycerol breath test by estimating carbon dioxide production from heart rate.

Slater C, Preston T, Weaver LT.

Eur J Clin Nutr. 2006 Nov;60(11):1245-52. Epub 2006 May 31.

PMID:
16736067
18.

Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.

Kinzig-Schippers M, Fuhr U, Zaigler M, Dammeyer J, Rüsing G, Labedzki A, Bulitta J, Sörgel F.

Clin Pharmacol Ther. 1999 Mar;65(3):262-74.

PMID:
10096258
19.

Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction.

Abraham K, Geusau A, Tosun Y, Helge H, Bauer S, Brockmöller J.

Clin Pharmacol Ther. 2002 Aug;72(2):163-74.

PMID:
12189363
20.
Items per page

Supplemental Content

Write to the Help Desk